☆ Ajouter favori
Fiche traitement

0.9% NaCl

Nelly Pitteloud Alzheimer

Suivi actif Phase 2

Résumé

0.9% NaCl est développé par Nelly Pitteloud. Le traitement est actuellement en Phase 2. Il est associé à Alzheimer. Son objectif thérapeutique principal est Immunomodulation. Le statut actuel est : suivi actif.

À vérifier

Immunomodulation
Phase 2
Nelly Pitteloud
Switzerland
Down syndrome (DS) is the most common chromosomal disorder; with the increasing life expectancy, about 80% of DS adults reach age 65 years old. Early Alzheimer's disease (AD) is the most common cause of death within this population. DS individuals already show AD neuropathology by the age of 30, while it becomes clinically recognized in their late forties. DS subjects also exhibit olfaction defects in adulthood. To date, there is no treatment available for the cognitive or olfactory defects in DS. The development of an effective treatment targeting cognitive dysfunction in DS adolescents/adults would be warranted. GnRH, a decapeptide secreted by hypothalamic neurons is the pilot light of reproduction in all mammals. Pulsatile GnRH acts on the gonadotrophs via the GnRH receptor (GNRHR) in the pituitary gland to stimulate LH and FSH, which themselves will act on the gonads to produce gametes and steroids. However, GNRHR are also expressed in cerebral cortex, hippocampus, amygdala, habenula, olfactory structures, and adrenal gland, suggesting that GnRH may have a role beyond reproduction. Recently, GnRH has been shown to be involved in the process of ageing and lifespan control. Notably, in murine models, GnRH acts as an anti-ageing factor, independent of sex hormones. While ageing is characterized by hypothalamic inflammation and diminished neurogenesis, particularly in the hypothalamus and the hippocampus, GnRH was able to promote adult neurogenesis. The regulation of GnRH secretion is complex and involves hormonal, neuronal input, and environmental factors. Prévot et al. recently explored cognition within the Ts65Dn model and showed an age-dependent loss of the ability to recognize new objects. Also, these mice exhibit defects in olfaction. Given the role of GnRH in anti-aging mice model, pulsatile GnRH or continuous GnRH infusion (leading to desensitization of the GNRHR) were given to the Ts65Dn mice for two weeks. Amazingly, pulsatile but not continuous GnRH therapy was able to recover cognitive and olfaction defects.
2024-02-09

Début phase actuelle
Non disponible dans les sources synchronisées
Timeline clinique

Phase 2
Préclinique
Phase 1
Phase 2
Phase 3
Approuvé

Objectif scientifique de l’étude

classification automatique vérifiable
Immunomodulation Confiance automatique : 66%

Aucune incohérence majeure détectée entre la maladie, l’objectif et la description.

Transparence et qualité de la fiche

données vérifiables
ClassificationCohérente automatiquement
Confiance de la fiche100 %
Source principaleSource officielle ou publication indexée
Dernière vérification2024-02-09
Anomalies détectées0
Validation humaineValidation humaine non effectuée
Donnée issue d’une source Donnée normalisée automatiquement Interprétation algorithmique

Classification scientifique multi-axes

ne pas confondre statut et résultat
État de l’étudeStatut inconnu
Disponibilité des résultatsRésultats à vérifier
InterprétationImpossible à déterminer
Niveau de preuveNon évaluable

Un essai terminé n’est pas nécessairement positif. Un essai arrêté n’est classé comme échec scientifique que lorsqu’un résultat ou une raison explicite le confirme.

Indicateurs factuels

sans score subjectif
Phase enregistréePhase 2
Études associées0
Publications associées13
Statut consolidéSuivi actif

Aucune chance de succès, note d’innovation, potentiel thérapeutique ou probabilité de commercialisation n’est calculé tant qu’un modèle validé et des données suffisantes ne sont pas disponibles.

Historique factuel de la molécule

14 événement(s) daté(s)

Cette liste reprend uniquement les dates trouvées dans les registres et publications liés. Elle ne constitue pas une prévision.

DateÉvénementSource
2024-02-09Dernière mise à jour des données0.9% NaClBiomedical Watch
2026-07-08PublicationSuperhydrophilic zwitterionic poly(ethyl methacrylate)--poly(carboxybetaine methacrylate) copolymers with highly stable self-assemblies in physiological media.RSC advances
2026-07-08PublicationSubchronic comparative assessment of graded ferrous sulfate doses on biochemical, histological, and multiorgan micromorphological changes in wistar rats.Open veterinary journal
2026-07-08PublicationSustainable soil improvement strategies for coral islands: Synergistic application of sludge/carboxymethyl cellulose-derived hydrogel and biochar.International journal of biological macromolecules
2026-07-10PublicationA multifunctional sodium alginate/chitosan composite hydrogel for saline-alkali soil remediation: Synthesis, characterization, and proof-of-concept for promoting crop growth.International journal of biological macromolecules
2026-07-12PublicationEffectiveness and safety of intra-articular hyaluronic acid SEMICAL GEL-B CROSS therapy in knee osteoarthritis (SEM-ART1): Study protocol for a randomized, placebo controlled, double-blind, cross-over clinical trial.PloS one
2026-07-12PublicationRetrospective evaluation of the treatment of term newborns with hypernatraemic dehydration over the last decade.BMJ paediatrics open
2026-07-15PublicationDevelopment of a nalmefene formulation suitable for a community-use auto-injector.British journal of clinical pharmacology
2026-07-23PublicationTherapeutic potential of flavonoids and rutin against inflammation-induced on a huntington animal model.PloS one
2026-07-23PublicationIn vivo tolerability of topical telavancin versus vancomycin in a murine ocular model.The Journal of antimicrobial chemotherapy
2026-08-08PublicationAntibiofilm action of ozonated sunflower oil against bacteria isolated from the uterus of mares susceptible to endometritis.Animal reproduction
2026-08-08PublicationInhaled sphingosine reduces bronchial Pseudomonas aeruginosa burden during porcine ex vivo lung perfusion and shows tissue delivery in explanted human lungs.Scientific reports
2026-08-16PublicationHypertonic saline protects the axo-myelinic interface acutely after contusive SCI and improves postural stability and balance as revealed by motion sequencing (MoSeq).Experimental neurology
2026-08-16PublicationLoss of NGAL protects against albumin-induced kidney inflammation and fibrosis.Renal failure

Début phase actuelle
Non disponible dans les sources synchronisées
Essais cliniques liés

0 essai(s)
NCT Titre Phase Statut administratif Pays Sponsor
Aucun essai lié pour le moment.

Publications liées

13 publication(s)

Publications liées

13 publication(s)
Titre PMID DOI Journal Date
Hypertonic saline protects the axo-myelinic interface acutely after contusive SCI and improves postural stability and balance as revealed by motion sequencing (MoSeq). Voir source 42309341 10.1016/j.expneurol.2026.115881 Experimental neurology
Loss of NGAL protects against albumin-induced kidney inflammation and fibrosis. Voir source 41877356 10.1080/0886022X.2026.2642530 Renal failure
Antibiofilm action of ozonated sunflower oil against bacteria isolated from the uterus of mares susceptible to endometritis. Voir source 42524657 10.1590/1984-3143-AR2025-0116 Animal reproduction
Inhaled sphingosine reduces bronchial Pseudomonas aeruginosa burden during porcine ex vivo lung perfusion and shows tissue delivery in explanted human lungs. Voir source 42562866 10.1038/s41598-026-65074-7 Scientific reports
Therapeutic potential of flavonoids and rutin against inflammation-induced on a huntington animal model. Voir source 42461930 10.1371/journal.pone.0339016 PloS one
In vivo tolerability of topical telavancin versus vancomycin in a murine ocular model. Voir source 42483981 10.1093/jac/dkag250 The Journal of antimicrobial chemotherapy
Development of a nalmefene formulation suitable for a community-use auto-injector. Voir source 42448614 10.1002/bcp.70685 British journal of clinical pharmacology
Effectiveness and safety of intra-articular hyaluronic acid SEMICAL GEL-B CROSS therapy in knee osteoarthritis (SEM-ART1): Study protocol for a randomized, placebo controlled, double-blind, cross-over clinical trial. Voir source 42424346 10.1371/journal.pone.0353120 PloS one
Retrospective evaluation of the treatment of term newborns with hypernatraemic dehydration over the last decade. Voir source 42431691 10.1136/bmjpo-2026-004893 BMJ paediatrics open
A multifunctional sodium alginate/chitosan composite hydrogel for saline-alkali soil remediation: Synthesis, characterization, and proof-of-concept for promoting crop growth. Voir source 42419537 10.1016/j.ijbiomac.2026.153405 International journal of biological macromolecules
Superhydrophilic zwitterionic poly(ethyl methacrylate)--poly(carboxybetaine methacrylate) copolymers with highly stable self-assemblies in physiological media. Voir source 42416714 10.1039/d6ra04099c RSC advances
Subchronic comparative assessment of graded ferrous sulfate doses on biochemical, histological, and multiorgan micromorphological changes in wistar rats. Voir source 42376110 10.5455/OVJ.2026.v16.i3.45 Open veterinary journal
Sustainable soil improvement strategies for coral islands: Synergistic application of sludge/carboxymethyl cellulose-derived hydrogel and biochar. Voir source 42379437 10.1016/j.ijbiomac.2026.153318 International journal of biological macromolecules

Sources officielles

liens de recherche

Dernière mise à jour des données : 2024-02-09

Ces sources sont proposées pour vérification. Les informations de la fiche doivent être confirmées dans les registres officiels ou les publications originales.